LHON Society

Views & Analysis

It’s hard to imagine suddenly losing your sight in your 20s, but that’s what happened to Richard Wheeler when he developed

News

Biogen and Ionis have revealed the first clinical results with tau-targeting Alzheimer's drug candidate diranersen, to a mixed response.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.